Higuita-Castro Nanomedicine Lab
Our Mission
The NHC NanoMedicine Lab at The Ohio State University develops innovative micro‑ and nanoscale technologies for regenerative medicine.
We specialize in developing engineered extracellular vesicles (eEVs) as non-viral delivery platforms to treat complex inflammatory and degenerative disorders.
Our work brings together engineering, biology, and medicine to create next‑generation therapies for conditions where current treatments fall short. By reprogramming cells, reducing inflammation, and restoring tissue function, we aim to transform how diseases are treated and to accelerate the path from scientific discovery to real‑world medical solutions.
Related Links
The NHC NanoMedicine Lab maintains an active presence across multiple departments and research facilities at The Ohio State University. Our work spans interdisciplinary spaces and leverages the strengths of several campus institutes, including those highlighted below. These facilities support our efforts in nanotechnology, gene therapy, cardiovascular research, and translational biomedical innovation.
The Gene Therapy Institute is an interdisciplinary community bringing together world-class faculty with diverse expertise in the area of gene therapy research. Through collaboration we are enabling the successful translation of basic science discoveries into new therapies that are accessible to affected populations around the globe.
